Leduc C - Search Results

1

Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC.

Gauvin C, Krishnan V, Kaci I, Tran-Thanh D, Bédard K, Albadine R, Leduc C, Gaboury L, Blais N, Tehfe M, Routy B, Florescu M. Gauvin C, et al. Among authors: leduc c. Curr Oncol. 2021 Jan 20;28(1):593-605. doi: 10.3390/curroncol28010059. Curr Oncol. 2021. PMID: 33498159 Free PMC article.

2

Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma.

Lepletier A, Madore J, O'Donnell JS, Johnston RL, Li XY, McDonald E, Ahern E, Kuchel A, Eastgate M, Pearson SA, Mallardo D, Ascierto PA, Massi D, Merelli B, Mandala M, Wilmott JS, Menzies AM, Leduc C, Stagg J, Routy B, Long GV, Scolyer RA, Bald T, Waddell N, Dougall WC, Teng MWL, Smyth MJ. Lepletier A, et al. Among authors: leduc c. Clin Cancer Res. 2020 Jul 15;26(14):3671-3681. doi: 10.1158/1078-0432.CCR-19-3925. Epub 2020 Apr 28. Clin Cancer Res. 2020. PMID: 32345648

3

Tepotinib Efficacy in a Patient with Non-Small Cell Lung Cancer with Brain Metastasis Harboring an HLA-DRB1-MET Gene Fusion.

Blanc-Durand F, Alameddine R, Iafrate AJ, Tran-Thanh D, Lo YC, Blais N, Routy B, Tehfé M, Leduc C, Romeo P, Stephenson P, Florescu M. Blanc-Durand F, et al. Among authors: leduc c. Oncologist. 2020 Nov;25(11):916-920. doi: 10.1634/theoncologist.2020-0502. Epub 2020 Sep 8. Oncologist. 2020. PMID: 32716573 Free PMC article.

4

Subsecond lung cancer detection within a heterogeneous background of normal and benign tissue using single-point Raman spectroscopy.

Leblond F, Dallaire F, Tran T, Yadav R, Aubertin K, Goudie E, Romeo P, Kent C, Leduc C, Liberman M. Leblond F, et al. Among authors: leduc c. J Biomed Opt. 2023 Sep;28(9):090501. doi: 10.1117/1.JBO.28.9.090501. Epub 2023 Sep 9. J Biomed Opt. 2023. PMID: 37692565 Free PMC article.

5

Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.

Yanagawa N, Leduc C, Kohler D, Saieg MA, John T, Sykes J, Yoshimoto M, Pintilie M, Squire J, Shepherd FA, Tsao MS. Yanagawa N, et al. Among authors: leduc c. J Thorac Oncol. 2012 Oct;7(10):1513-21. doi: 10.1097/JTO.0b013e3182641d4f. J Thorac Oncol. 2012. PMID: 22982652 Free article.

6

HSP90 Inhibitor Improves Lung Protection in Porcine Model of Donation After Circulatory Arrest.

Nasir BS, Landry C, Menaouar A, Germain JF, Der Sarkissian S, Stevens LM, Aceros H, Cailhier JF, Leduc C, Liberman M, Noiseux N, Ferraro P. Nasir BS, et al. Among authors: leduc c. Ann Thorac Surg. 2020 Dec;110(6):1861-1868. doi: 10.1016/j.athoracsur.2020.05.079. Epub 2020 Jul 9. Ann Thorac Surg. 2020. PMID: 32652069

7

Invasive Mucinous Adenocarcinomas With Spatially Separate Lung Lesions: Analysis of Clonal Relationship by Comparative Molecular Profiling.

Yang SR, Chang JC, Leduc C, Tan KS, Dogan S, Benayed R, Borsu L, Offin M, Drilon A, Travis WD, Arcila ME, Ladanyi M, Rekhtman N. Yang SR, et al. Among authors: leduc c. J Thorac Oncol. 2021 Jul;16(7):1188-1199. doi: 10.1016/j.jtho.2021.03.023. Epub 2021 Apr 8. J Thorac Oncol. 2021. PMID: 33839364 Free PMC article.

8

Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.

Naidoo J, Wang X, Woo KM, Iyriboz T, Halpenny D, Cunningham J, Chaft JE, Segal NH, Callahan MK, Lesokhin AM, Rosenberg J, Voss MH, Rudin CM, Rizvi H, Hou X, Rodriguez K, Albano M, Gordon RA, Leduc C, Rekhtman N, Harris B, Menzies AM, Guminski AD, Carlino MS, Kong BY, Wolchok JD, Postow MA, Long GV, Hellmann MD. Naidoo J, et al. Among authors: leduc c. J Clin Oncol. 2017 Mar;35(7):709-717. doi: 10.1200/JCO.2016.68.2005. Epub 2016 Sep 30. J Clin Oncol. 2017. PMID: 27646942 Free PMC article.

9

Composite mantle cell and primary cutaneous anaplastic large cell lymphoma: case report and review of the literature.

Leduc C, Blandino II, Alhejaily A, Baetz T, Good DJ, Farmer PL, Squire JA, LeBrun DP. Leduc C, et al. Am J Dermatopathol. 2015 Mar;37(3):232-6. doi: 10.1097/DAD.0000000000000233. Am J Dermatopathol. 2015. PMID: 25374307 Review.

10

Flavopiridol synergizes with sorafenib to induce cytotoxicity and potentiate antitumorigenic activity in EGFR/HER-2 and mutant RAS/RAF breast cancer model systems.

Nagaria TS, Williams JL, Leduc C, Squire JA, Greer PA, Sangrar W. Nagaria TS, et al. Among authors: leduc c. Neoplasia. 2013 Aug;15(8):939-51. doi: 10.1593/neo.13804. Neoplasia. 2013. PMID: 23908594 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

311 results

Search Page